These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 14576939)

  • 21. [Diagnostic problems of ovarian mucinous borderline tumors].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Jun; 53(2):127-33. PubMed ID: 19581178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
    de Nictolis M; Montironi R; Tommasoni S; Valli M; Pisani E; Fabris G; Prat J
    Int J Gynecol Pathol; 1994 Jan; 13(1):10-21. PubMed ID: 8112952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
    Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
    Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
    Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
    Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum.
    Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A
    Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study.
    Boman F; Buisine MP; Wacrenier A; Querleu D; Aubert JP; Porchet N
    J Pathol; 2001 Mar; 193(3):339-44. PubMed ID: 11241413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Taddei A; Taddei GL
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):127-31. PubMed ID: 15354737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
    Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
    BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
    Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
    Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
    Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
    Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S100P is a useful marker for differentiation of ovarian mucinous tumors.
    Umezaki Y; Ito M; Nakashima M; Mihara Y; Naruke Y; Kurohama H; Yatsunami N; Yasuhi I
    Eur J Gynaecol Oncol; 2015; 36(2):138-41. PubMed ID: 26050349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucinous tumors of the ovary: a review.
    Hart WR
    Int J Gynecol Pathol; 2005 Jan; 24(1):4-25. PubMed ID: 15626914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
    Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
    Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanylyl cyclase C is a specific marker for differentiating primary and metastatic ovarian mucinous neoplasms.
    Ciocca V; Bombonati A; Palazzo JP; Schulz S; Waldman SA
    Histopathology; 2009 Aug; 55(2):182-8. PubMed ID: 19694825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of CD44 expression in serous and mucinous borderline tumours of the ovary: comparison with cystadenomas and overt carcinomas.
    Darai E; Walker-Combrouze F; Fauconnier A; Madelenat P; Potet F; Scoazec JY
    Histopathology; 1998 Feb; 32(2):151-9. PubMed ID: 9543672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
    Zhong CQ
    Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary.
    Halimi SA; Maeda D; Shinozaki-Ushiku A; Koso T; Matsusaka K; Tanaka M; Arimoto T; Oda K; Kawana K; Yano T; Fujii T; Fukayama M
    Histopathology; 2013 Oct; 63(4):534-44. PubMed ID: 23905715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.